Pathobiology of the klotho antiaging protein and therapeutic considerations

GJ Prud'homme, M Kurt, Q Wang - Frontiers in Aging, 2022 - frontiersin.org
The α-Klotho protein (henceforth denoted Klotho) has antiaging properties, as first observed
in mice homozygous for a hypomorphic Klotho gene (kl/kl). These mice have a shortened …

[HTML][HTML] Aging-suppressor Klotho: Prospects in diagnostics and therapeutics

CR Abraham, A Li - Ageing Research Reviews, 2022 - Elsevier
Abstract Introduction The protein Klotho (KL) was first discovered in KL-deficient mice, which
developed a syndrome similar to premature aging in humans. Since then, KL has been …

Lipid accumulation and chronic kidney disease

Z Gai, T Wang, M Visentin, GA Kullak-Ublick, X Fu… - Nutrients, 2019 - mdpi.com
Obesity and hyperlipidemia are the most prevalent independent risk factors of chronic
kidney disease (CKD), suggesting that lipid accumulation in the renal parenchyma is …

Klotho, oxidative stress, and mitochondrial damage in kidney disease

J Donate-Correa, B Martín-Carro, JB Cannata-Andía… - Antioxidants, 2023 - mdpi.com
Reducing oxidative stress stands at the center of a prevention and control strategy for
mitigating cellular senescence and aging. Kidney disease is characterized by a premature …

Klotho as potential autophagy regulator and therapeutic target

H Zhou, S Pu, H Zhou, Y Guo - Frontiers in Pharmacology, 2021 - frontiersin.org
The protein Klotho can significantly delay aging, so it has attracted widespread attention.
Abnormal downregulation of Klotho has been detected in several aging-related diseases …

PPARγ and TGFβ—major regulators of metabolism, inflammation, and fibrosis in the lungs and kidneys

G Kökény, L Calvier, G Hansmann - International journal of molecular …, 2021 - mdpi.com
Peroxisome proliferator-activated receptor gamma (PPARγ) is a type II nuclear receptor,
initially recognized in adipose tissue for its role in fatty acid storage and glucose metabolism …

The role of peroxisome proliferator-activated receptors in kidney diseases

J Gao, Z Gu - Frontiers in Pharmacology, 2022 - frontiersin.org
Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone
receptor superfamily of ligand-activated transcription factors. Accumulating evidence …

A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor

M Oz, DE Lorke, N Kabbani - Pharmacology & therapeutics, 2021 - Elsevier
The recent emergence of coronavirus disease-2019 (COVID-19) as a global pandemic has
prompted scientists to address an urgent need for defining mechanisms of disease …

[HTML][HTML] Aging and renal disease: old questions for new challenges

YH Chou, YM Chen - Aging and disease, 2021 - ncbi.nlm.nih.gov
Chronic kidney disease (CKD) is a growing problem among aging population, and the
number of individuals at risk of end stage renal disease is rising. Part of the reason lies in …

Emerging role of α-Klotho in energy metabolism and cardiometabolic diseases

Y Liu, M Chen - Diabetes & Metabolic Syndrome: Clinical Research & …, 2023 - Elsevier
Background and aim Klotho was first identified as a gene associated with aging and
longevity in 1997. α-Klotho is an anti-aging protein and its role in energy metabolism …